Detailed information for compound 1436949

Basic information

Technical information
  • TDR Targets ID: 1436949
  • Name: [(4S,6R)-1,2,2,6-tetramethylpiperidin-4-yl] ( 2S)-2-hydroxy-2-phenylacetate
  • MW: 291.385 | Formula: C17H25NO3
  • H donors: 1 H acceptors: 2 LogP: 2.8 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C([C@H](c1ccccc1)O)O[C@H]1C[C@@H](C)N(C(C1)(C)C)C
  • InChi: 1S/C17H25NO3/c1-12-10-14(11-17(2,3)18(12)4)21-16(20)15(19)13-8-6-5-7-9-13/h5-9,12,14-15,19H,10-11H2,1-4H3/t12-,14+,15+/m1/s1
  • InChiKey: QSAVEGSLJISCDF-SNPRPXQTSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • [(4S,6R)-1,2,2,6-tetramethyl-4-piperidyl] (2S)-2-hydroxy-2-phenyl-acetate
  • (2S)-2-hydroxy-2-phenylacetic acid [(4S,6R)-1,2,2,6-tetramethyl-4-piperidinyl] ester
  • (2S)-2-hydroxy-2-phenyl-acetic acid [(4S,6R)-1,2,2,6-tetramethyl-4-piperidyl] ester
  • [(4S,6R)-1,2,2,6-tetramethylpiperidin-4-yl] (2S)-2-hydroxy-2-phenyl-ethanoate
  • NCGC00016499-01
  • CAS-536-93-6

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cytochrome P450, family 2, subfamily D, polypeptide 6 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi cytochrome P450 cytochrome P450, family 2, subfamily D, polypeptide 6 497 aa 425 aa 32.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni chromobox protein 0.0427 0.2028 0.1914
Schistosoma mansoni hypothetical protein 0.071 0.3599 0.3507
Echinococcus granulosus Jumonji AT rich interactive domain 1B 0.0247 0.1026 0.1527
Plasmodium falciparum JmjC domain-containing protein, putative 0.0063 0 0.5
Brugia malayi mbt repeat family protein 0.0991 0.5167 1
Brugia malayi jmjC domain containing protein 0.0297 0.1302 0.1139
Loa Loa (eye worm) jmjC domain-containing protein 0.0297 0.1302 0.1139
Echinococcus multilocularis histone acetyltransferase MYST2 0.0208 0.0806 0.1147
Plasmodium vivax JmjC domain containing protein 0.0063 0 0.5
Echinococcus multilocularis Jumonji, AT rich interactive domain 1B 0.0247 0.1026 0.1527
Onchocerca volvulus Polycomb protein Sfmbt homolog 0.0991 0.5167 1
Echinococcus granulosus endonuclease exonuclease phosphatase 0.113 0.5941 1
Schistosoma mansoni jumonji/arid domain-containing protein 0.0202 0.0772 0.064
Echinococcus multilocularis SAM and MBT domain containing protein 0.0835 0.4294 0.7161
Loa Loa (eye worm) hypothetical protein 0.0991 0.5167 1
Echinococcus multilocularis endonuclease exonuclease phosphatase 0.113 0.5941 1
Echinococcus granulosus SAM and MBT domain containing protein 0.0835 0.4294 0.7161
Schistosoma mansoni myelin transcription factor 1 myt1 0.0208 0.0806 0.0674
Echinococcus multilocularis polycomb protein SCMH1 0.0576 0.2856 0.4682
Schistosoma mansoni sex comb on midleg homolog 0.0576 0.2856 0.2754
Echinococcus multilocularis tumor suppressor p53 binding protein 1 0.071 0.3599 0.5962
Loa Loa (eye worm) mbt repeat family protein 0.06 0.2986 0.5001
Echinococcus granulosus suppression of tumorigenicity 18 protein 0.0208 0.0806 0.1147
Echinococcus granulosus polycomb protein SCMH1 0.0576 0.2856 0.4682
Schistosoma mansoni scm-relatedprotein containing 4 mbt domains (sfmbt) 0.0835 0.4294 0.4212
Echinococcus granulosus histone acetyltransferase MYST2 0.0208 0.0806 0.1147
Schistosoma mansoni jumonji/arid domain-containing protein 0.0202 0.0772 0.064
Schistosoma mansoni sex comb on midleg homolog 0.0576 0.2856 0.2754
Toxoplasma gondii PLU-1 family protein 0.0095 0.0179 1
Brugia malayi mbt repeat family protein 0.06 0.2986 0.5001
Echinococcus multilocularis lysine specific demethylase 5A 0.0168 0.0585 0.0766
Echinococcus granulosus lysine specific demethylase 5A 0.0202 0.0772 0.1089
Echinococcus granulosus chromobox protein 2 0.0427 0.2028 0.3253
Echinococcus multilocularis chromobox protein 2 0.0427 0.2028 0.3253
Echinococcus multilocularis suppression of tumorigenicity 18 protein 0.0208 0.0806 0.1147
Echinococcus granulosus tumor suppressor p53 binding protein 1 0.071 0.3599 0.5962

Activities

Activity type Activity value Assay description Source Reference
AC50 (functional) PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active ChEMBL. No reference
AC50 (functional) PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active ChEMBL. No reference
AC50 (functional) PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active ChEMBL. No reference
AC50 (functional) PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active ChEMBL. No reference
AC50 (functional) = 15.84893192 uM PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active ChEMBL. No reference
Potency (ADMET) = 15.8489 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ] ChEMBL. No reference
Potency (functional) 39.8107 uM PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.